DMRA · Damora Therapeutics, Inc. · Documents
$21.96
+0.70 (+3.29%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$1.36B
Shares
61.74M
Volume · Oct 27
286.1K
Avg daily vol (3M)
520.19K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2023-07-31 | 2023-06-30 | |
| 8-K | — | 2023-06-15 | 2023-06-14 | |
| 10-Q | — | 2023-04-28 | 2023-03-31 | |
| ARS | — | 2023-04-28 | 2022-12-31 | |
| DEF 14A | — | 2023-04-28 | 2023-06-14 | |
| DEFA14A | — | 2023-04-28 | — | |
| 8-K | — | 2023-03-10 | — | |
| 10-K | — | 2023-03-09 | 2022-12-31 | |
| 8-K | — | 2023-01-06 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-10-31 | — | |
| 8-K | — | 2022-09-29 | — | |
| 10-Q | — | 2022-07-29 | 2022-06-30 | |
| 8-K | — | 2022-06-17 | 2022-06-14 | |
| 10-Q | — | 2022-04-29 | 2022-03-31 | |
| DEF 14A | — | 2022-04-28 | — | |
| DEFA14A | — | 2022-04-28 | — | |
| 10-K | — | 2022-02-17 | 2021-12-31 | |
| 8-K | — | 2022-02-09 | 2022-02-03 | |
| 8-K | — | 2022-01-27 | — | |
| 8-K | — | 2022-01-05 | — | |
| S-3 | — | 2021-11-04 | — | |
| 10-Q | — | 2021-11-04 | 2021-09-30 | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-07-06 | 2021-06-30 | |
| 8-K | — | 2021-05-28 | 2021-05-26 | |
| 10-Q | — | 2021-05-04 | 2021-03-31 | |
| DEF 14A | — | 2021-04-14 | 2021-05-26 | |
| DEFA14A | — | 2021-04-14 | — | |
| 10-K | — | 2021-03-29 | 2020-12-31 | |
| 8-K | — | 2021-03-15 | — | |
| 8-K | — | 2021-01-08 | — | |
| 8-K | — | 2021-01-05 | — | |
| 10-Q | — | 2020-12-11 | 2020-09-30 | |
| 8-K | — | 2020-11-23 | 2020-11-19 | |
| 8-K | — | 2020-11-04 | 2020-11-02 | |
| S-1/A | — | 2020-10-22 | — | |
| S-1 | — | 2020-10-07 | — |
Showing 51–88 of 88 filings